Unknown

Dataset Information

0

A prospective, randomized, single-blind, multicentre, phase III study on organ preservation with Custodiol-N solution compared with Custodiol® solution in organ transplantation (kidney, liver and pancreas).


ABSTRACT: BACKGROUND:Organ preservation before transplantation is still a challenge. Both the University of Wisconsin and Bretschneider's histidine-tryptophan-ketoglutarate (HTK; Custodiol®) solution are standard for liver, kidney and pancreas preservation. Organ preservation with both solutions is comparable; recently, however, Custodiol® solution has been modified to Custodiol-N according to the needs of today. Thus, our study was defined to study its effect in clinical transplantation. METHODS:Patients undergoing kidney transplantation (n =?412) (including approximately 30 combined kidney-pancreas) or liver transplantation (n =?202) receive grafts that have been cold stored in either Custodiol® or Custodiol-N to demonstrate noninferiority of Custodiol-N regarding both graft function and graft injury after transplantation. DISCUSSION:Preclinical data have clearly shown that Custodiol-N is superior to Custodiol® in cold static organ preservation via mechanisms including inhibition of hypoxic cell injury, cold-induced cell injury and avoidance of adverse effects during warm exposure to the solution. Further clinical safety data on Custodiol-N for cardioplegia are available. Thus, this study was designed to compare Custodiol® with Custodiol-N for the first time in a prospective, randomized, single-blinded, multicentre, phase III clinical transplantation trial. TRIAL REGISTRATION:Eudra-CT, 2017-002198-20. Registered on 28 November 2018.

SUBMITTER: Kniepeiss D 

PROVIDER: S-EPMC6954515 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

A prospective, randomized, single-blind, multicentre, phase III study on organ preservation with Custodiol-N solution compared with Custodiol® solution in organ transplantation (kidney, liver and pancreas).

Kniepeiss Daniela D   Houben Philipp P   Stiegler Philipp P   Berghold Andrea A   Riedl Regina R   Kahn Judith J   Schemmer Peter P  

Trials 20200110 1


<h4>Background</h4>Organ preservation before transplantation is still a challenge. Both the University of Wisconsin and Bretschneider's histidine-tryptophan-ketoglutarate (HTK; Custodiol®) solution are standard for liver, kidney and pancreas preservation. Organ preservation with both solutions is comparable; recently, however, Custodiol® solution has been modified to Custodiol-N according to the needs of today. Thus, our study was defined to study its effect in clinical transplantation.<h4>Metho  ...[more]

Similar Datasets

| S-EPMC7662817 | biostudies-literature
| S-EPMC7117741 | biostudies-literature
| S-EPMC8583819 | biostudies-literature
| S-EPMC8714958 | biostudies-literature
| S-EPMC3857005 | biostudies-literature
| S-EPMC7998211 | biostudies-literature
| S-EPMC5894212 | biostudies-literature
| S-EPMC6914981 | biostudies-literature
| S-EPMC6886303 | biostudies-literature
| S-EPMC6546202 | biostudies-literature